|The SEMA3A sema3a (Catalog #MBS2090623) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Monoclonal Antibody to Semaphorin 3A (SEMA3A) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Semaphorin 3A (SEMA3A) can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP).
Western Blot: 0.5-5ug/mL
Immunocytochemistry: 5-30ug/mL. Researchers should empirically determine the suitability of the SEMA3A sema3a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The SEMA3A sema3a product has the following accession number(s) (GI #5174673) (NCBI Accession #NP_006071.1) (Uniprot Accession #Q14563). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Monoclonal Antibody to Semaphorin 3A (SEMA3A) with the following immunoassay(s):
Western Blot (WB) ((Figure. Western Blot; Sample: Recombinant SEMA3A, Human.))
Immunogen: Recombinant Semaphorin 3A (SEMA3A). Buffer Formulation: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing SEMA3A are readily searchable from our website. Different antibodies against the same target such as SEMA3A may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. SEMA3A also interacts with the following gene(s): CDK5, CRMP1, FARP2, NRP1, NRP2, PLXNA1, PLXNA3, PLXNA4, RAC1. Blood, Bone Marrow, Brain, Connective Tissue, Embryonic Tissue, Eye, Heart, Lung, Muscle, Skin tissues are correlated with this protein. Adenocarcinoma, Brain Diseases, Breast Neoplasms, Congenital Abnormalities, Drug Toxicity, Heart Diseases, Inflammation, Neoplasms, Nervous System Diseases, Pain are some of the diseases may be linked to Monoclonal Antibody to Semaphorin 3A (SEMA3A). The following patways have been known to be associated with this gene.